Medicus Pharma Ltd. (MDCX)
NASDAQ: MDCX · Real-Time Price · USD
3.950
-0.011 (-0.28%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Medicus Pharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Medicus Pharma stock have an average target of 12, with a low estimate of 10 and a high estimate of 14. The average target predicts an increase of 203.80% from the current stock price of 3.95.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Medicus Pharma stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 2 |
Buy | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +254.43% | Apr 21, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +254.43% | Apr 14, 2025 |
Maxim Group | Maxim Group | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +153.16% | Dec 17, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | ||
Avg | n/a | n/a | n/a | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | - | - | - | |
Avg | - | - | - | |
Low | - | - | - |
EPS Forecast
EPS | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|
High | -2.58 | -0.96 | -0.58 | ||
Avg | -2.51 | -1.22 | -0.80 | ||
Low | -2.41 | -1.34 | -0.89 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | - | - | - | |
Avg | - | - | - | |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.